drugset / Trial / NCT05021094
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
RandomizedFactorialQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of Kuntai capsule alone or combined with hormone therapy in improving ovarian function in POI patients (including subclinical stage).
Timeline
- Start
- 2021-10-22
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dydrogesterone | Other / unclassified | 10 mg | Oral |
| Subject | Estradiol | Other / unclassified | 2 mg | Oral |
| Subject | Kuntai Capsule | Unknown | 2 g | Oral |